Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources High-Tech Natural Pharmaceutical is a specialized subsidiary of China Resources Pharmaceutical Group, focused on the research, development, and manufacturing of natural and botanical medicines. Headquartered in Beijing, the company utilizes advanced extraction and purification technologies to modernize traditional Chinese medicine (TCM) for clinical use. Its product portfolio primarily targets cardiovascular and cerebrovascular diseases, featuring standardized extracts such as Ginkgo biloba and Puerarin. The company operates high-standard GMP manufacturing facilities and serves as a critical R&D hub within the broader China Resources healthcare ecosystem. By bridging traditional knowledge with modern pharmaceutical science, it aims to provide high-quality natural therapeutic options for the Chinese and global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Resources High-Tech Natural Pharmaceutical.